Expertise in
15
conditions

Dr. Mahesh R. Kudrimoti

Radiation Oncology
Radiation Oncology-Dearborn Cancer Center-St. Elizabeth Healthcare
17525 Greendale Plaza Dr, 
Greendale, IN 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Expertise in
15
conditions
Radiation Oncology-Dearborn Cancer Center-St. Elizabeth Healthcare
17525 Greendale Plaza Dr, 
Greendale, IN 

Overview

Mahesh Kudrimoti is a Radiation Oncologist practicing medicine in Greendale, Indiana.

Dr. Kudrimoti is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Fibrolamellar Carcinoma, Teratocarcinosarcoma, and Pancreaticoduodenectomy.

He is actively involved in clinical research, co-authoring 39 peer reviewed articles and participating in 6 clinical trials. Dr. Kudrimoti is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in KY

Hospital Affiliations

St Elizabeth Edgewood
St Elizabeth Dearborn Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
MDwise
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

Radiation Oncology-Dearborn Cancer Center-St. Elizabeth Healthcare
17525 Greendale Plaza Dr, Greendale, IN 47025

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer
Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer
Enrollment Status: Recruiting
Publish Date: August 17, 2026
Intervention Type: Procedure, Drug, Other
Study Phase: Phase 2/Phase 3
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2026
Intervention Type: Other, Procedure, Drug, Biological, Radiation
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 2/Phase 3
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
Enrollment Status: Completed
Publish Date: February 23, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Capecitabine, Chemotherapy, Erlotinib hydrochloride, Fluorouracil, Gemcitabine hydrochloride
Study Phase: Phase 3
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 06, 2026
Intervention Type: Biological, Radiation
Study Drug: Cetuximab
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of GC4419 on Severe Oral Mucositis in Patients Receiving Cisplatin + Intensity-modulated Radiation Therapy (IMRT) for Locally Advanced Non-Metastatic Squamous Cell Carcinoma (SCC) of the Oral Cavity/Oropharynx
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of GC4419 on Severe Oral Mucositis in Patients Receiving Cisplatin + Intensity-modulated Radiation Therapy (IMRT) for Locally Advanced Non-Metastatic Squamous Cell Carcinoma (SCC) of the Oral Cavity/Oropharynx
Enrollment Status: Completed
Publish Date: September 20, 2021
Intervention Type: Radiation, Drug
Study Phase: Phase 2
Correlative Study of Nicotine Levels With Response Rates to Therapy Using Radiation Alone or in Combination With Chemotherapy in Head and Neck Cancer
Correlative Study of Nicotine Levels With Response Rates to Therapy Using Radiation Alone or in Combination With Chemotherapy in Head and Neck Cancer
Enrollment Status: Completed
Publish Date: July 14, 2021
View 5 Less Clinical Trials

39 Total Publications

A Two-Stage Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ec-18 in Altering the Severity and Course of Oral Mucositis Secondary to Chemoradiation Therapy for Squamous Cell Cancers of the Head and Neck.
A Two-Stage Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ec-18 in Altering the Severity and Course of Oral Mucositis Secondary to Chemoradiation Therapy for Squamous Cell Cancers of the Head and Neck.
Journal: Cancers
Published: March 30, 2025
Similar Doctors
Expertise in
18
conditions
Dr. Jordan R. Kharofa
Radiation Oncology
Expertise in
18
conditions
Dr. Jordan R. Kharofa
Radiation Oncology
Referral may be required

West Chester Hospital Radiotherapy Center

7710 Discovery Dr, 
West Chester, OH 
 (30.2 miles away)
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jordan Kharofa is a Radiation Oncologist practicing medicine in West Chester, Ohio. He has been practicing medicine for over 17 years. Dr. Kharofa is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Anal Cancer, Pancreatic Cancer, Squamous Cell Carcinoma of the Anal Canal (SCAC), Pancreaticoduodenectomy, and Pancreatectomy. Dr. Kharofa is currently accepting new patients.

Expertise in
6
conditions
Dr. Vinita Takiar
Radiation Oncology
Expertise in
6
conditions
Dr. Vinita Takiar
Radiation Oncology
Referral may be required

Barrett Building-Breast Imaging

3151 Bellevue Ave, 
Cincinnati, OH 
 (17.6 miles away)
513-584-3494
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Vinita Takiar is a Radiation Oncologist practicing medicine in Cincinnati, Ohio. Dr. Takiar is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, Laryngeal Cancer, Oral Squamous Cell Carcinoma, and Gastrostomy. Dr. Takiar is currently accepting new patients.

Expertise in
30
conditions
Dr. John C. Breneman
Radiation Oncology
Expertise in
30
conditions
Dr. John C. Breneman
Radiation Oncology
Referral may be required

University Of Cincinnati Medical Center

3199 Highland Ave, 
Cincinnati, OH 
 (17.6 miles away)
513-584-4775
Languages Spoken:
English
See accepted insurances
Accepting New Patients

John Breneman is a Radiation Oncologist practicing medicine in Cincinnati, Ohio. Dr. Breneman is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Meningioma, Brain Tumor, Optic Glioma, and Radiation Induced Meningioma. Dr. Breneman is currently accepting new patients.

Frequently Asked Questions about Dr. Mahesh R. Kudrimoti

How do I make an appointment with Dr. Mahesh R. Kudrimoti?

You can book an appointment with Dr. Mahesh R. Kudrimoti by calling their office at 859-301-2238. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mahesh R. Kudrimoti a top-rated expert for Laryngeal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mahesh R. Kudrimoti is classified as an Distinguished expert for Laryngeal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mahesh R. Kudrimoti specialize in?

While Dr. Mahesh R. Kudrimoti is a Radiation Oncology, they have specific expertise in Laryngeal Cancer, Throat Cancer, and Fibrolamellar Carcinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Mahesh R. Kudrimoti participate in research or clinical trials?

Yes. Dr. Mahesh R. Kudrimoti has published 39 articles and abstracts on conditions like Laryngeal Cancer. You can view a list of Dr. Mahesh R. Kudrimoti's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mahesh R. Kudrimoti accept my insurance?

Dr. Mahesh R. Kudrimoti accepts most major insurance plans, including Anthem BCBS and Blue Cross Blue Shield. We recommend calling the office directly at 859-301-2238 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kudrimoti's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 61 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile